MMP2 and neoplasm: In a cohort of women with high grade serous carcinoma, an increased MMP-9 tumor expression, quantified by automated immunostaining, was associated with a higher risk of death but not with tumor progression; however, no correlation of protein expression with TIMP-2 and MMP-2 with death or tumor progression was observed in the same patient cohort [187].